» Articles » PMID: 35564002

Risk-Benefit Assessment of an Increase in the Iodine Fortification Level of Foods in Denmark-A Pilot Study

Overview
Journal Foods
Specialty Biotechnology
Date 2022 May 14
PMID 35564002
Authors
Affiliations
Soon will be listed here.
Abstract

Iodine deficiency is one of the most common nutritional disorders worldwide. In Denmark, the mandatory iodine fortification of salt of 13 ppm was introduced in 2000 to eradicate mild to moderate iodine deficiency and the fortification level was increased to 20 ppm in 2019. However, the optimal iodine intake is a narrow interval, and the risk of disease increases with intakes both below and above this interval. In this study, we quantified the risk-benefit balance in the Danish adult population by increasing the mandatory fortification level. We applied a risk-benefit assessment approach in which population-level iodine intakes before and after the increase in fortification were integrated with epidemiological evidence of the association between iodine nutrition status and risk of relevant diseases to estimate the number of cases caused or prevented and estimated health impact in terms of disability-adjusted life years (DALY). We estimated an overall beneficial health impact and prevention of 34.9 (95% UI: -51.6; -21.7) DALY per 100,000 adults in the population annually with the increase in fortification level. Prevention of low IQ in children due to maternal iodine deficiency was the primary contributor to overall health gain. The gain in healthy life years comes at the expense of extra cases of goiter due to iodine excess. Due to lack of data, hypo- and hyperthyroidism related to iodine status were not included. Neither were children as a population group. Because of this, as well as uncertainties inherent in the model and data used, results should be interpreted with caution. We argue that nation-specific, quantitative assessments of the public health impact of fortification programs provide transparent, evidence-based decision support. Future research should aim to enable the inclusion of all relevant health effects as well as children in the assessment.

Citing Articles

Risk-benefit assessment of foods and its role to inform policy decisions: outcome of an international workshop.

Matteu Monteiro C, Membre J, Poulsen M, Thomsen S, Pires S Front Nutr. 2024; 11:1458531.

PMID: 39385787 PMC: 11462872. DOI: 10.3389/fnut.2024.1458531.


Iodine and plant-based diets: a narrative review and calculation of iodine content.

Nicol K, Nugent A, Woodside J, Hart K, Bath S Br J Nutr. 2023; 131(2):265-275.

PMID: 37622183 PMC: 10751939. DOI: 10.1017/S0007114523001873.

References
1.
Zimmermann M, Jooste P, Pandav C . Iodine-deficiency disorders. Lancet. 2008; 372(9645):1251-62. DOI: 10.1016/S0140-6736(08)61005-3. View

2.
Hoekstra J, Verkaik-Kloosterman J, Rompelberg C, van Kranen H, Zeilmaker M, Verhagen H . Integrated risk-benefit analyses: method development with folic acid as example. Food Chem Toxicol. 2007; 46(3):893-909. DOI: 10.1016/j.fct.2007.10.015. View

3.
Rasmussen L, Andersson G, Haraldsdottir J, Kristiansen E, Molsted K, Laurberg P . Iodine. Do we need an enrichment program in Denmark?. Int J Food Sci Nutr. 1996; 47(5):377-81. DOI: 10.3109/09637489609006950. View

4.
Krejbjerg A, Bjergved L, Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H . Thyroid nodules in an 11-year DanThyr follow-up study. J Clin Endocrinol Metab. 2014; 99(12):4749-57. DOI: 10.1210/jc.2014-2438. View

5.
Laurberg P, Jorgensen T, Perrild H, Ovesen L, Knudsen N, Bulow Pedersen I . The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006; 155(2):219-28. DOI: 10.1530/eje.1.02210. View